Anantapur Hospital Accredited to Test Drug Resistant TB Sample

Prader-Willi syndrome Investigational Drug into FDA Fast Track Mode while Phase III Study Continues

The Indian Ministry of Health’s TB division has accredited the Anantapur Rural Development Trust (RDT) Hospital’s laboratory at Bhatalapalli in Anantapur district to test multi-drug-resistant tuberculosis (MRD-TB) samples. It is the second facility in this Indian state to earn this achievement.
In the facility resides a negative pressure laboratory, where line probe assay was performed using nucleic acid amplication and polymerase chain reaction (PCR) technology to detect mutations associated with drug resistance, said TB control officer Ravela Sudheer Babu.
MDR-TB is caused by bacteria to isoniazid and rifampin, first-line anti-TB medications.  Visakhapatnam is the only other accredited facility in the state.
The National Research Institute, Chennai, and the TB Research Institute, New Delhi,  inspected the hospital for six months.  A number of tests were performed at the genetic structure-level of TB bacteria that could help detect the drug resistance status within two days, and a second or third line of drugs could be administered to the patients.
The mycobacteriology laboratory was opened in June 2018.  It was partially funded by the General Insurance Corporation (Re) of Ind...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee